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The laboratory genetic testing is rapidly emerging in clinical
practice. Recently, in parallel with the report of human
genome project, next generation sequencing techniques are
widely applied to study human genome providing a basis for
integrating information about genome, exome, and transcrip-
tome of a living organism. The future applications of genetic
testing are discussed in popularmedia everyday. Accordingly,
this special issue was prepared to provide a basis for integrat-
ing information from this emerging field. Among them, we
have given place to research articles as well as clinical studies.
Although polymorphism studies have lost their significance
compared to previous years when genetic studies gained
popularity, some polymorphisms in the genome have been
reported to play considerable role in development of patho-
logical conditions. Their importance in nasopharyngeal car-
cinoma, osteosarcoma, and pediatric tuberculosis is reported
in 3 research articles. Integrated diagnostic approach includ-
ing clinical and biochemical analysis followed by genetic
tests was discussed in children with neurodevelopmental and
neurometabolic diseases. Notwithstanding a great deal of
advanced genetic testing that has become available, cytoge-
netics never lost its importance. One of the studies points
out that patients benefit from the information that could
be provided by cytogenetics in clinical decision-making,
followup, and prognosis in myelodysplastic syndrome. On
the other hand, fragile X, which is the most common genetic
cause in hereditary intellectual disability syndromes, was
discussed on a basis of a large number of enrolled subjects.
Genetic variant in hepatitis C virus and its effect in the course
of antiviral treatment were also evaluated in chronic hepatitis
C patients and has made an important contribution to the
knowledge of patients’ management. Finally and undoubt-
edly, next generation studies as a robust and cost-effective
genetic technology have found place in this special issue in
3 clinical studies relating to the breast and ovarian cancer,
Charcot-Marie-Tooth disease, and retinitis pigmentosa.
In summary we aimed to combine reports relating to
various genetic technologies in a number of disease condi-
tions. However, as mentioned in the review article by A. A.
Durmaz et al., novel technologies in the field of genetics have
noticeably accelerated in the last few decades. Even though
Moore’s law will continuously apply to the developmental
speed in computer technologies, the cost of sequencing has
declined and the data obtained from NGS platforms has
increased at a rate that outpaced Moore’s law. Recently a new
era has clearly begun with genetics to be one of the major
players in human life. In the near future, it will be possible
to estimate the risks and prepare prevention strategies for
a number of genetically based conditions just by analyzing
a few drops of blood. Genetic cloning, genetic engineered
organisms, extreme longevity, artificial intelligence, and per-
sonalized treatment will become a reality.
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